Jiangxi Fushine Pharmaceutical Co.,Ltd.’s Net Profit Dropped 78.6% in First Half of 2022

Jiangxi Fushine Pharmaceutical Co.,Ltd. (江西富祥药业股份有限公司) (300497.SZ) reported a net profit of 32.5 million yuan in the first half of 2022, down 78.6% year-on-year.

Meanwhile, the company posted 831.1 million yuan in revenue, up 7.1% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 42.8%.